Heterogeneity in treatment response in patients with HER2 positive breast cancer

被引：0
|
作者：
Prat, A. [1 ]
机构：
[1] Hosp Clin Barcelona, Med Oncol, Barcelona, Spain
来源：
BREAST | 2019年 / 44卷
关键词：
D O I：
10.1016/S0960-9776(19)30068-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SA 3.1
引用
收藏
页码：S3 / S4
页数：2
相关论文
共 50 条
  • [1] Heterogeneity in treatment response in patients with HER2 positive breast cancer
    Carey, L. A.
    BREAST, 2019, 44 : S5 - S5
  • [2] Treatment of HER2 positive breast cancer patients
    Matos, Erika
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2012, 81 (03): : 236 - 245
  • [3] The response to treatment with anastrozole and tamoxifen in HER2 positive breast cancer patients
    Snoj, N
    Drev, P
    Golouh, R
    Cufer, T
    ANNALS OF ONCOLOGY, 2005, 16 : 276 - 276
  • [4] The association of higher tumor HER2 load with treatment response to neoadjuvant therapy in HER2 positive breast cancer patients
    Lillemoe, T. J.
    Susnik, B.
    Grimm, E.
    Kang, S-H L.
    Swenson, K. K.
    Krueger, J. L.
    Finkelstein, M. J.
    Tsai, M. L.
    CANCER RESEARCH, 2017, 77
  • [5] HER2 heterogeneity in breast cancer
    Sala, Elena
    Saccheri, Fabiana
    Crosti, Francesca
    Villa, Nicoletta
    Gautiero, Eugenio
    Brenna, Ambrogio
    Dalpra, Leda
    CHROMOSOME RESEARCH, 2013, 21 : S112 - S112
  • [6] Intra-tumor heterogeneity as a predictor of therapy response in HER2 positive breast cancer
    Rye, I. H.
    Helland, A.
    Saetersdal, A.
    Naume, B.
    Almendro, V.
    Polyak, K.
    Boressen-Dale, A-L
    Russnes, H. G.
    CANCER RESEARCH, 2012, 72
  • [7] Quantitative measurements of HER2 expression and HER2: HER2 dimerization identify subgroups of HER2 positive metastatic breast cancer patients with different probabilities of response to trastuzumab treatment
    Huang, W.
    Lipton, A.
    Leitzel, K.
    Ali, S. M.
    Fuchs, E. M.
    Weidler, J.
    Chappey, C.
    Sperinde, J.
    Tan, Y.
    Jin, X.
    Paquet, A.
    Winston, J.
    Petropoulos, C.
    Kostler, W. J.
    Bates, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S86 - S86
  • [8] HER2 Heterogeneity Is Associated with Poor Survival in HER2-Positive Breast Cancer
    Hosonaga, Mari
    Arima, Yoshimi
    Sampetrean, Oltea
    Komura, Daisuke
    Koya, Ikuko
    Sasaki, Takashi
    Sato, Eiichi
    Okano, Hideyuki
    Kudoh, Jun
    Ishikawa, Shumpei
    Saya, Hideyuki
    Ishikawa, Takashi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (08)
  • [9] HER2 positive breast cancer
    Gianni, Luca
    Bianchini, Giampaolo
    CANCER RESEARCH, 2023, 83 (05)
  • [10] HER2 Heterogeneity Affects Trastuzumab Responses and Survival in Patients With HER2-Positive Metastatic Breast Cancer
    Lee, Hee Jin
    Seo, An Na
    Kim, Eun Joo
    Jang, Min Hye
    Suh, Koung Jin
    Ryu, Han Suk
    Kim, Yu Jung
    Kim, Jee Hyun
    Im, Seock-Ah
    Gong, Gyungyub
    Jung, Kyung Hae
    Park, In Ae
    Park, So Yeon
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2014, 142 (06) : 755 - 766
12345